Global health sciences venture fund
North America, British Columbia, Canada, Vancouver
Description
The strength of the life science industry
Investor Profile
Global health sciences venture fund has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 22% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, France, Spain.
- Strong thematic focus on Biotechnology, Therapeutics, Life Science.
Stage Focus
- Series C (33%)
- Series A (22%)
- Series B (22%)
- Seed (11%)
- Series D (11%)
Country Focus
- United States (78%)
- France (11%)
- Spain (11%)
Industry Focus
- Biotechnology
- Therapeutics
- Life Science
- Health Care
- Pharmaceutical
- Medical
- Genetics
- Health Diagnostics
- Medical Device
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.